All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @maddieshae23 on TikTok · 156s|Watch on TikTok

@maddieshae23's GLP-1 side effects list, fact-checked

Maddie | Health Journey + Tips

TikTok creator

33.7K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying and reduce appetite, leading to significant weight loss. Clinical trials show 14.9% average weight reduction with semaglutide 2.4mg and up to 22.5% with tirzepatide 15mg. Most side effects are gastrointestinal and temporary.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @maddieshae23's GLP-1 side effects list, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@maddieshae23's GLP-1 side effects list, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@maddieshae23's GLP-1 side effects list, fact-checked" from Maddie | Health Journey + Tips. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying and reduce appetite, leading to significant weight loss.

The reason this review is not generic is the source wording and the canonical claim label "glp1 some common side effects nausea constipation diarrh." In this clip, the useful excerpt is: "Some common side effects ⬇️ - nausea - constipation - diarrhea - bloating & gas - fatigue - dizziness & headaches - hair thinning" That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Digestive side effects like constipation (24%) and diarrhea (16-23%) are common but often manageable
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying and reduce appetite, leading to significant weight loss.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists like semaglutide and tirzepatide slow gastric emptying and reduce appetite, leading to significant weight loss. Clinical trials show 14.9% average weight reduction with semaglutide 2.4mg and up to 22.5% with tirzepatide 15mg. Most side effects are gastrointestinal and temporary.
  • Nausea affects 44% of semaglutide users according to STEP 1 trial data, but typically decreases after 4-8 weeks
  • Digestive side effects like constipation (24%) and diarrhea (16-23%) are common but often manageable

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Nausea affects 44% of semaglutide users according to STEP 1 trial data, but typically decreases after 4-8 weeks
  • Digestive side effects like constipation (24%) and diarrhea (16-23%) are common but often manageable
  • Most GLP-1 side effects are temporary and can be reduced by following proper dose escalation schedules
  • Hair thinning isn't established as a direct drug effect in major trials and may be related to rapid weight loss
  • Starting doses of 0.25mg weekly for semaglutide help minimize side effects compared to faster titration
  • Fatigue and headaches occur in roughly 11% and 6% of users respectively, less than the video implies
  • Serious but rare side effects like pancreatitis (0.2% incidence) weren't mentioned but require medical attention

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this TikTok claim?

@maddieshae23 lists seven side effects of GLP-1 medications: nausea, constipation, diarrhea, bloating and gas, fatigue, dizziness and headaches, and hair thinning. She presents these as "common" without specifying which drugs or what percentage of users experience them.

The video appears aimed at people considering or starting GLP-1 medications for weight loss. Her approach is straightforward but lacks the context that would help viewers understand how likely these effects actually are.

Does the science back up her list?

Most of her claims are accurate based on clinical trial data. The STEP 1 trial (Wilding et al., NEJM, 2021) found that 44% of semaglutide users experienced nausea, making it the most common side effect. Constipation affected 24% of participants.

The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed similar patterns with tirzepatide. Nausea occurred in 12-22% of users depending on dose, while diarrhea affected 16-23%. Fatigue and dizziness appeared in roughly 11% and 6% of participants respectively.

Hair thinning is where things get murkier. While some users report it, major trials don't list alopecia as a common adverse event. This might be related to rapid weight loss rather than the medication itself.

What did she miss about timing and severity?

@maddieshae23's biggest omission is that most GLP-1 side effects are temporary and dose-dependent. The STEP trials showed that nausea typically peaks during the first 4-8 weeks and decreases as the body adjusts.

She also doesn't mention that side effects often correlate with how quickly you increase the dose. The standard semaglutide protocol starts at 0.25mg weekly and increases every four weeks to minimize problems.

More serious but rare side effects like pancreatitis (0.2% incidence) or gastroparesis don't make her list. While these affect fewer people, they're more medically significant than the common but mild effects she focuses on.

What should you actually expect?

The data suggests you'll probably feel nauseous for the first month, especially after dose increases. About half of people experience this, but it usually fades. Digestive issues like constipation or diarrhea affect roughly one in four users.

The fatigue and headaches @maddieshae23 mentions are real but less predictable. They might be related to eating less food or adjusting to the medication's effects on blood sugar.

Her hair thinning claim needs perspective. Rapid weight loss from any cause can trigger temporary hair loss called telogen effluvium. This isn't necessarily a direct drug effect and typically resolves once weight stabilizes.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Maddie | Health Journey + Tips · TikTok creator

33.7K views on this video

Some common side effects ⬇️ - nausea - constipation - diarrhea - bloating & gas - fatigue - dizziness & headaches - hair thinning #wellnessjourney#healthyliving#lifestylechange#glp1journey#glp1side

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about nausea affects 44% of semaglutide users according to step 1?

Nausea affects 44% of semaglutide users according to STEP 1 trial data, but typically decreases after 4-8 weeks

What does the video say about digestive side effects like constipation (24%)?

Digestive side effects like constipation (24%) and diarrhea (16-23%) are common but often manageable

What does the video say about most glp-1 side effects?

Most GLP-1 side effects are temporary and can be reduced by following proper dose escalation schedules

What does the video say about hair thinning?

Hair thinning isn't established as a direct drug effect in major trials and may be related to rapid weight loss

What does the video say about starting doses of 0.25mg weekly for semaglutide help minimize side?

Starting doses of 0.25mg weekly for semaglutide help minimize side effects compared to faster titration

What does the video say about fatigue?

Fatigue and headaches occur in roughly 11% and 6% of users respectively, less than the video implies

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Maddie | Health Journey + Tips, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.